SCOPUS 정보 검색 플랫폼

Personalized Medicine

Volumn 9, Issue 3, 2012, Pages 237-239

Genomic pathology: A disruptive innovation

(1) Saffitz, Jeffrey E a

a HARVARD MEDICAL SCHOOL (United States)

Author keywords

disruptive innovation; genomic pathology; next generation sequencing; whole genome analysis

Indexed keywords

LIPIDOME; PROTEOME; TRANSCRIPTOME;

COST EFFECTIVENESS ANALYSIS; CYTOGENETICS; DIAGNOSIS; DISEASE MANAGEMENT; EDITORIAL; GENE SEQUENCE; GENOME ANALYSIS; GENOMIC PATHOLOGY; HIGH THROUGHPUT SEQUENCING; HISTOCOMPATIBILITY; HUMAN; HUMAN GENOME; LIFESTYLE MODIFICATION; METABOLOME; MICROBIOME; NEXT GENERATION SEQUENCING; PATHOLOGY; PERSONALIZED MEDICINE; PRIORITY JOURNAL; PROPHYLAXIS; RISK ASSESSMENT; SEQUENCE ANALYSIS;

EID: 84860765981 PISSN: 17410541 EISSN: 1744828X Source Type: Journal
DOI: 10.2217/pme.12.5 Document Type: Editorial

Times cited : (7)

References (8)

1
- 84860728408
- The next $100 billion technology business
- Forbes
- Herper M. The next $100 billion technology business. 30 December Forbes (2010
- (2010) 30 December
- Herper, M.¹

2
- 84860781743
- Quotes attributed to George Church
- Quotes attributed to George Church. 24 April Newsweek (2011
- (2011) 24 April Newsweek

3
- 79954592811
- A national agenda for the future of pathology in personalized medicine
- Tonellato PJ, Crawford JM, Boguski MS, Saffitz JE. A national agenda for the future of pathology in personalized medicine. Am. J. Clin. Pathol. 135(5), 668-672 (2011
- (2011) Am. J. Clin. Pathol. , vol.135 , Issue.5 , pp. 668-672
- Tonellato, P.J.¹ Crawford, J.M.² Boguski, M.S.³ Saffitz, J.E.⁴

4
- 84860717032
- Between hype and hope: Whole-genome sequencing in clinical medicine
- 243-239
- Schrijver I, Galli SJ. Between hype and hope: whole-genome sequencing in clinical medicine. Per. Med. 9(3), 243-239 (2012
- (2012) Per. Med. , vol.9 , Issue.3
- Schrijver, I.¹ Galli, S.J.²

5
- 84860713572
- TRIG on TRACK: Educating pathology residents in genomic medicine
- Haspel RL, JB Atkinson, FG Barr. TRIG on TRACK: educating pathology residents in genomic medicine. Per. Med. 9(3), 287-293 (2012
- (2012) Per. Med. , vol.9 , Issue.3 , pp. 287-293
- Haspel, R.L.¹ Atkinson, J.B.² Barr, F.G.³

6
- 84860736773
- Deriving clinical action from whole-genomic analysis
- Wall DP, Tonellato PJ. Deriving clinical action from whole-genomic analysis. Per. Med. 9(3), 247-252 (2012
- (2012) Per. Med. , vol.9 , Issue.3 , pp. 247-252
- Wall, D.P.¹ Tonellato, P.J.²

7
- 84860759749
- Modernizing US regulatory and reimbursement policy to support continued nnovation in genomic pathology
- Walcoff SD, Pfeifer JD. Modernizing US regulatory and reimbursement policy to support continued nnovation in genomic pathology. Per. Med. 9(3), 295-308 (2012
- (2012) Per. Med. , vol.9 , Issue.3 , pp. 295-308
- Walcoff, S.D.¹ Pfeifer, J.D.²

8
- 84860724939
- The business value and cost-effectiveness of genomic medicine
- Crawford JM, Aspinall MG. The business value and cost-effectiveness of genomic medicine. Per. Med. 9(3), 265-239 (2012)
- (2012) Per. Med. , vol.9 , Issue.3 , pp. 265-239
- Crawford, J.M.¹ Aspinall, M.G.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.